Success Metrics

Clinical Success Rate
62.5%

Based on 5 completed trials

Completion Rate
63%(5/8)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
3(27%)

Phase Distribution

Ph phase_2
1
9%
Ph phase_4
1
9%
Ph not_applicable
2
18%
Ph phase_3
1
9%
Ph phase_1
4
36%

Phase Distribution

4

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
4(44.4%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(5)
Terminated(3)
Other(2)

Detailed Status

Completed5
Terminated3
unknown2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
62.5%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (44.4%)
Phase 21 (11.1%)
Phase 31 (11.1%)
Phase 41 (11.1%)
N/A2 (22.2%)

Trials by Status

completed545%
unknown218%
terminated327%
not_yet_recruiting19%

Recent Activity

0 active trials
Showing 5 of 11
terminatedphase_4

Routine Antibiotic vs. Directed Antibiotic Treatment in Snake Bite

NCT02570347
not_yet_recruitingphase_1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants

NCT06939777
completedphase_1

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of GR2001 in Chinese Healthy Adults

NCT06302374
completednot_applicable

Detection of Aluminium-reactive T-lymphocytes in Patients With Vaccination Granulomas

NCT06130462
completedphase_1

Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00639639
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT02570347Phase 4

Routine Antibiotic vs. Directed Antibiotic Treatment in Snake Bite

Terminated
NCT06939777Phase 1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants

Not Yet Recruiting
NCT06302374Phase 1

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of GR2001 in Chinese Healthy Adults

Completed
NCT06130462Not Applicable

Detection of Aluminium-reactive T-lymphocytes in Patients With Vaccination Granulomas

Completed
NCT00639639Phase 1

Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Completed
NCT02628886Phase 3

Protecting From Pneumococcus in Early Life (The PROPEL Trial)

Unknown
NCT03535779

Characterisation of Human B Cell Maturation in Response to Vaccination

Completed
NCT00000105

Vaccination With Tetanus and KLH to Assess Immune Responses.

Terminated
NCT00369291Phase 1

CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant

Terminated
NCT00027833Phase 2

Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer

Unknown
NCT00004735Not Applicable

The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV

Completed

All 11 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
11